AzTrials
AzTrials

Post Operative PainNCT05141955

Ultrasound Guided Erector Spinae Plane Block Versus Quadratus Lumborum Block for Postoperative Analgesia in Patients Undergoing Laparoscopic Sleeve Gastrectomy

A study testing Group Erector Spinae Plane Block (ESPB) and Group Quadratus Lumborum Block (QLB) in people with Post Operative Pain, run by Ain Shams University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Postoperative pain control is a significant challenge in medical practice. Inadequate pain control could decrease patient's satisfaction, delay postoperative ambulation, increase the incidence of pulmonary and cardiac complications and cause the development of chronic postoperative pain. Read more about this study

Who is it for?
Ages 21 to 60 years
Conditions the study is for
Post Operative Pain
What is being tested?
Group Erector Spinae Plane Block (ESPB) and Group Quadratus Lumborum Block (QLB)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
120 participants
Where
1 siteEgypt
Study dates
15 Dec 2021to 15 Jun 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Patients with free medical history or controlled hypertension and/ or diabetes scheduled for elective laparoscopic sleeve gastrectomy.
  • BMI > 35 kg/ m2

Who cannot join

  • Patients unfit for surgery or refuse to sign the consent of regional block.
  • Patients with known coagulation defects.
  • Patients with known hypersensitivity to bupivacaine.
  • Patients with infection at the site of injection.
  • Conversion of laparoscopic surgery to laparotomy

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Ain-Shams University Hospitals

    Cairo

Other trials in Egypt

About this study

Official title: A Randomized Controlled Trial for Postoperative Analgesia in Patients Undergoing Laparoscopic Sleeve Gastrectomy: Ultrasound Guided Erector Spinae Plane Block Versus Quadratus Lumborum Block

Postoperative pain control is a significant challenge in medical practice. Inadequate pain control could decrease patient's satisfaction, delay postoperative ambulation, increase the incidence of pulmonary and cardiac complications and cause the development of chronic postoperative pain. Laparoscopic surgical techniques could decrease postoperative pain and opioid consumption.

The addition of regional techniques to general anesthesia showed better pain management and less consumption of opioids compared to the traditional techniques.

The aim of this study is to compare the effectiveness of ultrasound guided erector spinae plane block versus quadratus lumborum block regarding postoperative analgesia in patients undergoing laparoscopic sleeve gastrectomy.

Being tested
Group Erector Spinae Plane Block (ESPB), Group Quadratus Lumborum Block (QLB), Group (C) (Control group)
Medical subject headings
Pain, Postoperative

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Group Erector Spinae Plane Block (ESPB)Other

    Patients will receive general anesthesia initially then bilateral ESPB with a total volume of (0.3-0.4 ml/kg LBW) of bupivacaine 0.25% will be performed (not exceeding toxic dose) 150 mg "

  • Group Quadratus Lumborum Block (QLB)Other

    Patients will receive general anesthesia initially then bilateral QLB with a total volume of (0.3-0.4 ml/kg LBW) of bupivacaine 0.25% will be performed "not exceeding toxic dose150 mg "

  • Group (C) (Control group)Other

    Where patients will be operated under general anesthesia.

Study groups in NCT05141955
Study groupRoleWhat they receive
Group Erector Spinae Plane Block (ESPB)Active comparatorNot described
Receives: Other: Group Erector Spinae Plane Block (ESPB)
Group Quadratus Lumborum Block (QLB)Active comparatorNot described
Receives: Other: Group Quadratus Lumborum Block (QLB)
Group (C) (Control group)OtherNot described
Receives: Other: Group (C) (Control group)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Time to first requested rescue analgesia(Minutes)

    Time to first requested rescue analgesia(Minutes)

    Measured: 24 hours postoperatively

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Dec 2021
  2. Study start15 Dec 2021
  3. Primary completion15 Jun 2022
  4. Study completion15 Jun 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Care provider
Enrolment
120 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05141955
Sponsor's protocol ID
FMASU MS 705/ 2021
Status last verified
Jun 2022
First submitted
30 Nov 2021
Last updated
28 Jun 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Group Erector Spinae Plane Block (ESPB) and Group Quadratus Lumborum Block (QLB) in people with Post Operative Pain, run by Ain Shams University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Jun 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Time to first requested rescue analgesia(Minutes) (time frame: 24 hours postoperatively). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jun 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in